GARDASIL 9

NDC 0006-4119, Human Papillomavirus 9-valent Vaccine, Recombinant, injection, suspension, from Merck Sharp & Dohme LLC.

Product NDC: 0006-4119
Status: Listed
Labeler: Merck Sharp & Dohme LLC
Dosage form: INJECTION, SUSPENSION
Route: INTRAMUSCULAR
Product type: VACCINE
Marketing category: BLA
Application: BLA125508
DEA schedule: None

Request

curl https://api.healthcare.dev/v1/drugs/ndc/0006-4119 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN30 ug/.5mL
HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN40 ug/.5mL
HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN60 ug/.5mL
HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN40 ug/.5mL
HUMAN PAPILLOMAVIRUS TYPE 31 L1 CAPSID PROTEIN ANTIGEN20 ug/.5mL
HUMAN PAPILLOMAVIRUS TYPE 33 L1 CAPSID PROTEIN ANTIGEN20 ug/.5mL
HUMAN PAPILLOMAVIRUS TYPE 45 L1 CAPSID PROTEIN ANTIGEN20 ug/.5mL
HUMAN PAPILLOMAVIRUS TYPE 52 L1 CAPSID PROTEIN ANTIGEN20 ug/.5mL
HUMAN PAPILLOMAVIRUS TYPE 58 L1 CAPSID PROTEIN ANTIGEN20 ug/.5mL

Pharmacologic classes

Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Inactivated Human Papillomavirus Vaccine [EPC]; Inactivated Human Papillomavirus Vaccine [EPC]; Inactivated Human Papillomavirus Vaccine [EPC]; Inactivated Human Papillomavirus Vaccine [EPC]; Papillomavirus Vaccines [CS]; Papillomavirus Vaccines [CS]; Papillomavirus Vaccines [CS]; Papillomavirus Vaccines [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]

Package NDC	NDC-11	Package
0006-4119-03	00006411903	10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4119-03) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4119-01)

Linked data

RxNorm, label and prices

RxNorm concepts

15970990.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection [Gardasil 9] (SBD)

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0006-4119 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/ndc/0006-4119 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up NDC 0006-4119. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Get a free key NDC docs Connect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.